跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 77 条关于
“Lexitas”
全部
77
临床试验
38
药物
14
机构
1
资讯
24
2个月前
Lexitas and Ocusun Launch Pilot Study of Lanosterol-Derived Eye Drop for Age-Related Cataract
去年
Ophthalmic Clinical Trial Enrollment Trends and Insights Revealed at AAOpt 2024
去年
jCyte Initiates Phase 2 Trial of Famzeretcel Cell Therapy for Retinitis Pigmentosa
3年前
Editas Medicine Advances EDIT-301 for Sickle Cell Disease and Beta Thalassemia, Prioritizes In Vivo Gene Editing
去年
Editas Medicine's Reni-Cel Shows Promise in Sickle Cell Disease Treatment
去年
Editas Medicine Achieves In Vivo Gene Editing Milestones, Plans Clinical Push
6个月前
Illumina Partners with Veritas Genetics to Integrate Whole-Genome Sequencing into Health Insurance Plans
去年
Federal Circuit Remands CRISPR Patent Dispute to PTAB in Ongoing Editas Medicine Case
11个月前
Takeda Exits Cell Therapy Research, Takes $395 Million Impairment Loss
去年
AstraZeneca Exits Neuroscience Research to Focus on Core Therapeutic Areas
第 1 页,共 3 页
上一页
下一页